ERBB2 and neoplasm: Conjugated with HER2, a pH, GSH and HAase triple-responsive nanoplatform GNR-HA-ALA/Cy7.5-HER2 (ALA: 5-aminolevulinic acid) was reported by Yao and co-workers.84In vivo experiments illustrated that tumor tissues could be completely eliminated without obvious side effects.